Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selvi Durmus

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 25, 2016
The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized miceSelvi Durmus, Stéphanie van Hoppe, Alfred H Schinkel
Advances in Cancer Research|February 3, 2015
Apical ABC transporters and cancer chemotherapeutic drug dispositionSelvi Durmus, Jeroen J M A Hendrikx, Alfred H Schinkel
Expert Opinion on Drug Discovery|December 16, 2020
CRISPRing future medicinesLaure Grand Moursel, Mijke Visser, Geraldine Servant, et al.
RNA (New York, N.Y.)|April 29, 2010
MicroRNAs, macrocontrol: regulation of miRNA processingIzabella Slezak-Prochazka, Selvi Durmus, Bart-Jan Kroesen, et al.
Molecular Pharmaceutics|October 2, 2012
Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridarSelvi Durmus, Rolf W Sparidans, Els Wagenaar, et al.
International Journal of Cancer|February 21, 2014
In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transportersSelvi Durmus, Jyoti Naik, Levi Buil, et al.
Journal of Inorganic Biochemistry|September 5, 2015
Cationic Pd(II)/Pt(II) 5,5-diethylbarbiturate complexes with bis(2-pyridylmethyl)amine and terpyridine: Synthesis, structures,DNA/BSA interactions, intracellular distribution, cytotoxic activity and induction of apoptosisCeyda Icsel, Veysel T Yilmaz, Yunus Kaya, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2013
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasmaRolf W Sparidans, Selvi Durmus, Alfred H Schinkel, et al.
Pharmaceutical Research|January 8, 2015
Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)Anita Kort, Selvi Durmus, Rolf W Sparidans, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 30, 2013
Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasmaRolf W Sparidans, Selvi Durmus, Alfred H Schinkel, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 25, 2016
The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized miceSelvi Durmus, Stéphanie van Hoppe, Alfred H Schinkel
Advances in Cancer Research|February 3, 2015
Apical ABC transporters and cancer chemotherapeutic drug dispositionSelvi Durmus, Jeroen J M A Hendrikx, Alfred H Schinkel
Expert Opinion on Drug Discovery|December 16, 2020
CRISPRing future medicinesLaure Grand Moursel, Mijke Visser, Geraldine Servant, et al.
RNA (New York, N.Y.)|April 29, 2010
MicroRNAs, macrocontrol: regulation of miRNA processingIzabella Slezak-Prochazka, Selvi Durmus, Bart-Jan Kroesen, et al.
Molecular Pharmaceutics|October 2, 2012
Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridarSelvi Durmus, Rolf W Sparidans, Els Wagenaar, et al.
International Journal of Cancer|February 21, 2014
In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transportersSelvi Durmus, Jyoti Naik, Levi Buil, et al.
Journal of Inorganic Biochemistry|September 5, 2015
Cationic Pd(II)/Pt(II) 5,5-diethylbarbiturate complexes with bis(2-pyridylmethyl)amine and terpyridine: Synthesis, structures,DNA/BSA interactions, intracellular distribution, cytotoxic activity and induction of apoptosisCeyda Icsel, Veysel T Yilmaz, Yunus Kaya, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2013
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasmaRolf W Sparidans, Selvi Durmus, Alfred H Schinkel, et al.
Pharmaceutical Research|January 8, 2015
Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)Anita Kort, Selvi Durmus, Rolf W Sparidans, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 30, 2013
Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasmaRolf W Sparidans, Selvi Durmus, Alfred H Schinkel, et al.
Pageof 2